Home・Aktien・STRATEC Biomedical AG

STRATEC Biomedical AG

Geschlossen

23.35 0.21

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

22.95

Max

23.45

Schlüsselkennzahlen
By Trading Economics
Einkommen	5.9M 4.2M
Verkäufe	5.7M 59M
EPS	0.342
Dividendenrendite	2.54
Gewinnspanne	7.041
Angestellte	1,383
EBITDA	4.4M 8.5M

Empfehlungen
By TipRanks
Empfehlungen	Buy
12-Monats-Prognose	+23.4% upside

Dividenden
By Acuity
Dividendenrendite Branchendurchschnitt	2.54% 3.34%
Nächstes Ergebnis	12. Nov. 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	27M 274M
Vorheriger Eröffnungskurs	23.14
Vorheriger Schlusskurs	23.35

STRATEC Biomedical AG Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

24. Okt. 2026, 23:51 UTC

Building Permits MoM Final Data for September 2026 Expected to Decline by -0.2% Amid Cautious Market Sentiment Ahead of Release on October 27.

24. Okt. 2026, 23:51 UTC

Australia's Q3 2026 Producer Price Inflation Expected to Rise Slightly Amid Mixed Economic Sentiment and Rising Oil Prices.

24. Okt. 2026, 23:42 UTC

PCE Price Index MoM for September 2026 set to release on October 29, with a forecasted increase of 0.5%, amid cautious market sentiment and rising inflation concerns influenced by geopolitical tensions and mixed economic signals.

24. Okt. 2026, 23:42 UTC

U.S. Q3 2026 GDP Growth Rate Release on October 29 Expected at 3.2% Amid Mixed Market Sentiment and Inflation Concerns

24. Okt. 2026, 23:42 UTC

Core PCE Price Index for September 2026 set to release on October 29, with a forecasted increase of 0.3%, amid cautious investor sentiment ahead of key economic indicators and FOMC meetings.

24. Okt. 2026, 23:42 UTC

Upcoming Q3 2026 GDP Price Index Release on October 29 Expected to Signal Inflation Trends Amid Rising Oil Prices and Market Volatility.

24. Okt. 2026, 23:42 UTC

US Personal Income Expected to Rise 0.3% in September Amid Cautious Economic Sentiment and Inflation Concerns

24. Okt. 2026, 23:42 UTC

Upcoming PCE Price Index Release on October 29, 2026, Sparks Market Caution Amid Inflation Concerns and Potential Rate Hikes.

24. Okt. 2026, 23:42 UTC

Personal Spending MoM data for September 2026 set to release on October 29, with a forecasted increase of 0.3%, amid cautious optimism and rising consumer cost concerns.

24. Okt. 2026, 23:31 UTC

Brazil's Unemployment Rate for September 2026 Set to Release on October 30, with Analysts Expecting Stability at 5.3% Amid Positive Economic Trends.

24. Okt. 2026, 23:31 UTC

Mexico's Q3 2026 GDP Growth Rate Release on October 30 Faces Pressure from Geopolitical Tensions and Inflationary Concerns.

24. Okt. 2026, 23:31 UTC

Mexico's GDP Growth Rate Expected to Show Continued Recovery Amid Global Economic Uncertainty Ahead of October 30 Release.

24. Okt. 2026, 23:31 UTC

S&P/Case-Shiller Home Price Index Set for October 27 Release, Anticipating 2.6% Growth Amid Economic Uncertainties and Fed Rate Hike Concerns.

24. Okt. 2026, 23:31 UTC

South Africa's Balance of Trade data set for October 30, showing potential continued export strength amid cautious optimism.

24. Okt. 2026, 23:31 UTC

Brazil's Central Bank to announce interest rate decisions on October 26, with cautious optimism reflected in rising $EWZ ETF amid global inflation concerns.

24. Okt. 2026, 23:21 UTC

Upcoming U.S. Retail Inventories Ex Autos Data Release on October 28, 2026 Expected to Impact Consumer Spending and Economic Outlook Amid Inflation Concerns.

24. Okt. 2026, 23:21 UTC

Wholesale Inventories Data Release on October 28 Expected to Show 0.4% Growth Amid Cautious Market Sentiment and Rising Oil Prices.

24. Okt. 2026, 23:21 UTC

U.S. Goods Trade Balance for September 2026 Expected to Show $128.7 Billion Deficit Amid Tariff Policy Changes and Geopolitical Tensions

24. Okt. 2026, 23:21 UTC

Macro News

News

Bitcoin declines amid ongoing geopolitical tensions and El Salvador's new 0% tax rate on gains, requiring only a 90-day residency for individuals.

24. Okt. 2026, 23:11 UTC

Australia's RBA Trimmed Mean CPI release on October 28 sparks cautious market sentiment amid declining stocks and rising inflation concerns.

24. Okt. 2026, 23:11 UTC

Japan's Retail Sales Expected to Rise 3.3% YoY Amid Inflation and Market Volatility Concerns

24. Okt. 2026, 23:11 UTC

Australia's Inflation Rate Expected to Rise to 4.2% in September, Influencing Global Economic Sentiment and Interest Rate Speculations

24. Okt. 2026, 23:11 UTC

Japan's Industrial Production MoM data for September 2026 is expected to show a modest recovery of +1.3% after two months of contraction, amid mixed economic signals and cautious investor sentiment.

24. Okt. 2026, 23:01 UTC

US Durable Goods Orders Ex Transportation Expected to Rise 0.006% Amid Cautious Market Sentiment Ahead of Fed Policy Meeting

24. Okt. 2026, 23:01 UTC

Durable Goods Orders for September 2026 Expected to Rise by 0.6% Amid Cautious Market Sentiment and Key Economic Events Ahead

24. Okt. 2026, 23:01 UTC

Ethereum is declining, continuing a downward trend since Friday's close amid challenging broader market conditions and geopolitical tensions, positioned below its 20-day moving average.

24. Okt. 2026, 22:51 UTC

Japan's September 2026 unemployment rate forecast at 2.5% sparks cautious market sentiment amid economic volatility and rising inflation pressures.

24. Okt. 2026, 22:41 UTC

MBA 30-Year Mortgage Rate Release on October 28 Expected Amid Cautious Optimism Following Recent Decline to 7.41%

24. Okt. 2026, 22:41 UTC

Cautious Market Sentiment Ahead of Chicago Fed National Activity Index Release Amid Rising Oil Prices and Volatile Equity Markets

24. Okt. 2026, 22:31 UTC

Mexico's Balance of Trade Report on October 27 Sparks Caution Amid Mixed Expectations and U.S. Tariff Changes.

Peer-Vergleich

Kursveränderung

STRATEC Biomedical AG Prognose

Kursziel

By TipRanks

23.4% Vorteil

12-Monats-Prognose

Durchschnitt 29 EUR 23.4%

Hoch 37 EUR

Tief 21 EUR

Basierend auf 2 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für STRATEC Biomedical AG – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

2 ratings

Buy

Halten

Sell

Basierend auf 2 Analysten, die in den letzten 3 Monaten Aktienbewertungen für STRATEC Biomedical AG – Dist abgegeben haben.

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über STRATEC Biomedical AG

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.